Danske Bank A/S Insulet Corp Transaction History

Danske Bank A/S

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$277.3 - $352.82 $9.64 Million - $12.3 Million	34,755 New	34,755 $10.7 Million
Q2 2025 Dec 18, 2025	BUY	$238.57 - $327.47 $1.74 Million - $2.39 Million	7,313 Added 11.05%	73,481 $23.1 Million
Q1 2025 Dec 18, 2025	BUY	$237.06 - $288.29 $7.45 Million - $9.06 Million	31,413 Added 90.38%	66,168 $17.4 Million

913

60.5M

325K

557K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $23.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

Stay updated on Danske Bank A/S with notifications on news.